"We are now celebrating the 20th anniversary of the first-in-human TAVR procedure," write David R. Holmes Jr., MD, MACC, and Michael J. Mack MD, MACC. "We have witnessed a monumental shift in the management of a disease in a relatively short period of time. We also should celebrate all the collateral benefits."

Read the full article in Cardiology.